| Secondary |
| Hypertension |
34.4% |
| Pain |
24.6% |
| Drug Use For Unknown Indication |
9.8% |
| Product Used For Unknown Indication |
9.8% |
| Bipolar Disorder |
6.6% |
| Depression |
4.9% |
| Diabetes Mellitus |
3.3% |
| Gastric Ulcer |
3.3% |
| Diuretic Therapy |
1.6% |
| Epilepsy |
1.6% |
|
| Fatigue |
21.4% |
| Weight Increased |
21.4% |
| Thyroid Function Test Abnormal |
14.3% |
| Urinary Tract Infection |
14.3% |
| Blood Triglycerides Increased |
7.1% |
| Disseminated Intravascular Coagulation |
7.1% |
| Hypokalaemia |
7.1% |
| Multi-organ Failure |
7.1% |
|
| Concomitant |
| Hypertension |
34.8% |
| Product Used For Unknown Indication |
8.0% |
| Pain |
6.6% |
| Rheumatoid Arthritis |
5.6% |
| Gastritis |
5.4% |
| Glomerulonephritis Membranoproliferative |
4.9% |
| Breast Cancer Metastatic |
3.4% |
| Prophylaxis |
3.4% |
| Type 2 Diabetes Mellitus |
3.4% |
| Depression |
3.2% |
| Multiple Myeloma |
3.2% |
| Ill-defined Disorder |
2.9% |
| Hypercholesterolaemia |
2.7% |
| Drug Use For Unknown Indication |
2.2% |
| Mineral Supplementation |
1.9% |
| Nephrotic Syndrome |
1.9% |
| Renal Cancer |
1.9% |
| Colitis Ulcerative |
1.7% |
| Hormone Replacement Therapy |
1.5% |
| Insomnia |
1.5% |
|
| Renal Failure |
15.9% |
| Vision Blurred |
11.0% |
| Vomiting |
9.8% |
| Renal Impairment |
8.5% |
| Endometrial Cancer |
4.9% |
| Rhabdomyolysis |
4.9% |
| Rhinorrhoea |
4.9% |
| Sudden Death |
4.9% |
| Alopecia |
3.7% |
| Pyrexia |
3.7% |
| Shock |
3.7% |
| Sinusitis |
3.7% |
| Uterine Cancer |
3.7% |
| Adenocarcinoma |
2.4% |
| Anaphylactoid Reaction |
2.4% |
| Cerebral Thrombosis |
2.4% |
| Cerebrovascular Accident |
2.4% |
| Diarrhoea |
2.4% |
| Hair Colour Changes |
2.4% |
| Hallucination, Visual |
2.4% |
|
| Interacting |
| Diabetes Mellitus |
50.0% |
| Epilepsy |
25.0% |
| Hypertension |
25.0% |
|
|
